CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 40.55% | +7.77% | — | |
| 2 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 17.74% | -4.55% | — | |
| 3 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 10.69% | -3.10% | — | |
| 4 | ALMS | Alumis INC | Stock-Other | 8.16% | +2.01% | — | |
| 5 | MLYS | Mineralys Therapeutics INC | Stock-Other | 7.39% | -3.40% | — | |
| 6 | DSGN | Design Therapeutics INC | Stock-Other | 6.85% | -1.08% | — | |
| 7 | NKTX | Nkarta INC | Stock-Other | 6.17% | -0.10% | — | |
| 8 | ✓ | Engene Holdings INC | Stock-Other | 1.48% | -0.40% | — | |
| 9 | KALAEUR | Kala Bio INC | Stock-Other | 0.98% | — | — |